Document:

Exhibit 10.8

 

EXECUTIVE CONSULTING AGREEMENT

 

This Agreement dated and made effective as of
the 22nd day of February, 2021.

 

BETWEEN:

 

HOLLYWEED NORTH CANNABIS INC.,
a company incorporated pursuant to the laws of Canada and having offices in Victoria, British Columbia (the “Corporation”)

 

- and -

 

AJK BIOPHARMACEUTICAL LLC – CANADIAN
CONSULTING SERIES, a company incorporated pursuant to the laws of Nevada and having offices in California, USA (the “Consultant”)

 

WHEREAS the Corporation wishes to retain
the services of the principal of the Consultant, in the capacity of Chief Scientific Officer of the Corporation, to assist in the furtherance
of its Business;

 

AND WHEREAS the Corporation and the Consultant
have agreed that their relationship will be governed by the terms and conditions of this Executive Consulting Agreement;

 

NOW THEREFORE THIS AGREEMENT WITNESSETH that
in consideration of the provision of services by the Consultant to the Corporation, and for other good and valuable consideration, the
receipt and sufficiency of which is acknowledged by the parties hereto, the parties hereto agree as follows:

 

ARTICLE
I.

DEFINITIONS AND INTERPRETATION

 

		1.1	In this Executive Consulting Agreement, including the recitals hereto, the following terms shall have
the following meanings:

 

		(a)	“Act” means the Canada Business Corporations Act, as amended;

 

		(b)	“Affiliated” has the meaning set out in the Act, and an “Affiliate” means one
of two or more Affiliated bodies corporate;

 

		(c)	“Agreement” means this Executive Consulting Agreement, as from time to time supplemented or
amended by one or more agreements entered into pursuant to the applicable provisions hereof;

 

		(d)	“Board of Directors” means the board of directors of the Corporation;

 

		(e)	“Business” means the delivery of pathways to innovative, science-based health and wellness
solutions in psychedelics;

 

		(f)	“Cause” means any reason which would entitle the Corporation to terminate this agreement without
notice or payment in lieu of notice at common law, or under the provisions of any other applicable law or regulation and includes, without
limiting the generality of the foregoing:

 

		(i)	fraud, misappropriation of the Corporation’s property or funds, embezzlement, malfeasance, misfeasance
or nonfeasance in office which is willfully or grossly negligent on the part of the Consultant;

 

		(ii)	the breach by the Consultant of any of his covenants or obligations under this Agreement, including any
non-competition, non-solicitation or confidentiality covenants with the Corporation;

 

    

    

    

 

		(g)	“Change of Control” means the occurrence of any of the following (other than as a consequence
of the Exchange Listing):

 

		(i)	the purchase or acquisition by whatever means of any Shares or Convertible Securities by a Holder which
results in the Holder beneficially owning, or exercising control or direction over, Shares or Convertible Securities such that, assuming
the conversion of Convertible Securities beneficially owned or over which control or direction is exercised by the Holder, the Holder
would beneficially own or exercise control or direction over Shares (together with such Holder’s then owned Shares and Convertible
Securities, if any) carrying the right to cast more than 51% of the votes attaching to all Shares;

 

		(ii)	the amalgamation, consolidation or merger of the Corporation with any other corporation pursuant to which
the shareholders of the Corporation immediately prior to such transaction do not own shares of the successor or continuing corporation
which would entitle them to cast a majority of the votes attaching to shares in the capital of the successor or continuing corporation
which might be cast to elect directors of that corporation;

 

		(iii)	the sale, lease or transfer by the Corporation of all or substantially all of the assets of the Corporation
to any Person other than a Related Corporation;

 

		(iv)	approval by the shareholders of the Corporation of the liquidation, dissolution or winding-up of the Corporation;
or

 

		(v)	a situation in which the majority of the Board of Directors, following a meeting of the shareholders of
the Corporation involving a contest for, or an item of business relating to, the election of directors, are not management nominees to
the Board of Directors.

 

		(h)	“Common Shares” means the common shares in the capital stock of the Corporation;

 

		(i)	“Compensation” means any amounts the Consultant is entitled to receive pursuant to Article
IV.

 

		(j)	“Compensation Committee” means the committee of the Board of Directors appointed from time
to time to consider and determine executive compensation issues or, in the absence of such a committee, means the Board of Directors;

 

		(k)	“Confidential Information” means any information of a confidential nature which relates to
the Business of the Corporation or any Related Corporation, including trade secrets, technical information, patents, marketing strategies,
sales and pricing policies, financial information, business, marketing or technical plans, programs, methods, techniques, concepts, formulas,
documentation, intellectual property, software, industrial designs, products, technical studies and data, strategic studies, engineering
information, client and supplier lists, shareholder data and personnel information. Notwithstanding the foregoing, Confidential Information
shall not include any information which:

 

		(i)	was in the possession of or known to the Consultant, without any obligation to keep it confidential, before
it was disclosed to the Consultant by the Corporation;

 

		(ii)	is or becomes public knowledge through no fault of the Consultant;

 

		(iii)	is independently developed by the Consultant outside the scope of his duties to the Corporation;

 

		(iv)	is disclosed by the Corporation to another Person without any restriction on its use or disclosure; or

 

		(v)	is, or becomes lawfully available to the Consultant from a source other than the Corporation.

 

    2

    

    

 

		(l)	“Convertible Securities” means any securities convertible or exchangeable into Shares or carrying
the right or obligation to acquire Shares;

 

		(m)	“Corporate Property” includes any and all proprietary technology, financial, and operating
information, all works of expression and any copyrights in such works, patentable inventions, discoveries or trade secrets, and any materials,
tools, equipment, devices, records, files, data, tapes, computer programs, computer disks, software, communications, letters, proposals,
memoranda, lists, drawings, blueprints, correspondence, specifications or any other documents or property belonging to the Corporation
or any Related Corporations;

 

		(n)	“Dedicated Personnel” means Dr. Assad Kazeminy

 

		(o)	“Effective Date” means the date as set forth on page one of this Agreement;

 

		(p)	“Exchange” means a recognized Canadian or United States stock exchange;

 

		(q)	“Exchange Listing” means the listing of the Common Shares on an Exchange;

 

		(r)	“Excluded Reason” means the termination of this employment by the Corporation for Cause pursuant
to Section 5.2, by the Consultant pursuant to Section 6.1, or termination upon Death pursuant to Article VII;

 

		(s)	“Holder” means any Person or group of Persons acting jointly or in concert, or associated
or Affiliated with any such Person, group of Persons or any of such Persons acting jointly or in concert;

 

		(t)	“Notice” means any Notice given by one Party to the other Party in accordance with Article
XI;

 

		(u)	“Party” means one or other of the Consultant and the Corporation, and “Parties”
means both the Consultant and the Corporation;

 

		(v)	“Person” includes an individual, partnership, association, body corporate, trustee, executor,
administrator or legal representative, and “Persons” means a group of more than one Person;

 

		(w)	“Related Corporation” means any subsidiary corporation or partnership, division, affiliate,
predecessor or successor of the Corporation;

 

		(x)	“Severance Period” has the meaning as defined in 6.3(a) herein;

 

		(y)	“Shares” means the common shares of the Corporation as constituted on the date first above
written;

 

		(z)	“Term” means the period during which this Agreement remains in force pursuant to Article II;
and (aa)“Termination Date” means the last day actively worked by the Consultant for the Corporation.

 

    3

    

    

 

		1.2	The headings in this Agreement are inserted for convenience and ease of reference only, and shall not
affect the construction or interpretation of this Agreement.

 

		1.3	All words in this Agreement importing the singular number include the plural, and vice versa. All words
importing gender include the masculine, feminine and neuter genders.

 

		1.4	All monetary amounts are in United States dollars.

 

		1.5	The word “including”, when following any general statement or term, is not to be construed
as limiting the general statement or term to the specific items or matters set forth or to similar items or matters, but rather as permitting
the general statement or term to refer to all other items or matters that could reasonably fall within its broadest possible scope.

 

		1.6	A reference to a statute includes all regulations made thereunder, all amendments to the statute or regulations
in force from time to time, and any statute or regulation that supplements or supersedes such statute or regulations.

 

		1.7	A reference to an entity includes any successor to that entity.

 

		1.8	A reference to “approval”, “authorization” or “consent” means written
approval, authorization or consent.

 

		1.9	A reference to an Article is to an Article of this Agreement and the reference to a Section followed by
a number or some combination of numbers and letters refers to the section, paragraph, subparagraph, clause or subclause of this Agreement
so designated.

 

ARTICLE
II.

TERM OF AGREEMENT

 

		2.1	The Consultant’s engagement shall commence on the Effective Date and continue for a three (3) years
period in accordance with the provisions of this Agreement (the “Term”).

 

ARTICLE
III.

DUTIES OF CONSULTANT

 

		3.1	The Consultant shall, during the Term:

 

		(a)	perform the duties and responsibilities of the Chief Scientific Officer of the Corporation substantially
as described in Schedule “A” to this Agreement (the "Services").

 

    4

    

    

 

		3.2	Independent Contractor

 

		(a)	It is understood and agreed that the Consultant will provide services to the Corporation as an independent
contractor, on a contract basis, and that nothing in this Agreement shall be construed to create a relationship of employer and employee
between the Corporation and the Consultant. The Consultant acknowledges that it and the Dedicated Personnel will not be employees of the
Corporation and accordingly will not be eligible to participate in any employee benefit plans of the Corporation including, without limitation,
life insurance, health care, disability income and dental plans. The Consultant acknowledges that it is not, nor will it represent himself
to be, an employee of the Corporation.

 

		(b)	Except as provided for in this Agreement, the Corporation shall not control, supervise, direct or schedule
the activities of the Consultant. The Consultant shall be solely responsible for the performance of the Services and shall have the exclusive
direction and control, including the method, manner and scheduling of the same.

 

		(c)	It is acknowledged that the work product of the Consultant hereunder is the sole property of the Corporation
and the Consultant hereby assigns to the Corporation any proprietary interest and waives all moral rights he may be deemed to have in
the work product of the Consultant relating to or resulting from the performance of the Services hereunder. The Consultant will, under
no circumstances, use, copy, modify or disclose any such work product without the prior written consent of the Corporation.

 

		3.3	The Consultant shall be free to determine the hours of the day during which it will perform the Services;
provided, however, that the Consultant agrees, to the extent possible, to endeavour to make itself available to the directors and employees
of the Corporation during their regularly scheduled hours or at specific times as requested by the Corporation. The Consultant acknowledges
that the Services are to be completed on a timely basis and agrees that it shall schedule the performance of the Services in order to
complete the Services on or prior to such dates as may be reasonably specified by the Corporation from time to time. Notwithstanding
the foregoing, it is acknowledged that the Dedicated Personnel is also currently engaged in senior capacities with A ingeal Therapeutics
and AJK Biopharmaceutical and that as a result there will be unavoidable schedule conflicts from time to time that prevent the Consultant
from performing Services at specifically requested times. It is further acknowledged and agreed that the Services shall be for no more
than 20 hours per week.

 

		3.4	It is a condition of this agreement that all of the services performed hereunder shall be performed by
the Dedicated Personnel as an employee of the Consultant. In the event that the Dedicated Personnel is not available to perform any of
the services performed hereunder, for any reason whatsoever, then the Consultant shall promptly advise the Corporation accordingly. In
the event that the Consultant wishes to have any of these services performed hereunder by any other person, it shall obtain the written
permission of the Board of Directors of the Corporation in advance of the performance of the services by that other person.

 

ARTICLE
IV.

COMPENSATION

 

		4.1	The Corporation shall pay the Consultant during the Term of this Agreement for the Services provided hereunder
(the “Consulting Fee”), a fee of USD$180,000.00 per annum beginning on March 1, 2021, payable in monthly installments
on the first day of each month in arrears.

 

		4.2	The Consultant shall invoice the Corporation for Services provided on a monthly basis. The parties acknowledge
and agree that the Consulting Fee maybe subject to Canadian withholding tax and goods and services tax, depending on the extent to which
the services are performed in the United States. Additional performance bonuses and targets may be established on an annual basis by the
board of directors of the Corporation.

 

		4.3	Upon approval from the Board of Directors of the Corporation and regulatory
authorities, the Dedicated Personnel will be granted 3,000,000 stock options on a one-time basis. Each of these options will be priced
at CDN$0.12 per Common Share and will vest as to 1,000,000 upon the execution of this Agreement, and 500,000 options at the end of each
three month period during the Term, with the effect that all options shall have vested on the one year anniversary of the execution of
this Agreement

 

    5

    

    

 

		4.4	Except as specified below, all expenses incurred by the Consultant in connection with the performance
of the Services shall be the sole responsibility of the Consultant and the Consultant shall be solely responsible for the payment thereof.
The Consultant agrees and acknowledges that the Corporation is not responsible in any manner whatsoever for the costs, expenses or third
party accounts incurred by the Consultant. Notwithstanding the above, the Corporation agrees to reimburse the Consultant for, or to pay
directly, all third party costs incurred by the Consultant with the prior written authorization or approval of the Corporation. Such costs
and disbursements may include, but may not be limited to, computer equipment, communication devices and travel-related expenses. Such
costs will be paid or reimbursed by the Corporation within thirty (30) days of written receipt of payment thereof.

 

		4.5	The Consultant shall be responsible for all taxes payable as a result of the provision of the Services
or which arise out of this Agreement. The Consultant represents and warrants to the Corporation that it is a non-resident of Canada and
a resident of the United States of America for Canadian income and goods and services tax purposes

 

		4.6	If the Corporation should ever be required by any governmental authority at any time to pay, on the Consultant’s
behalf, any assessments such as income tax, employment insurance premiums, Canada Pension Plan contributions, Provincial/State Health
Care contributions, or Workers’ Compensation contributions, the Consultant will, forthwith upon notice, reimburse the Corporation
for such payment, together with interest and any penalties applicable to such assessments. The Consultant’s obligations under this
subsection 4.6 will survive the termination of this Agreement and remain in effect until the expiry of the period during which a notice
of assessment or reassessment in respect of the taxes under dispute may be issued and any further periods during which such assessment
or reassessment may be applied.

 

		4.7	The Corporation may also grant the Consultant annual or incentive bonuses in an amount and on such terms
and conditions as the Compensation Committee in its sole discretion may determine from time to time, based upon such factors as the Compensation
Committee in its sole discretion determines are relevant, which factors may include the Consultant’s performance under the terms
of this Agreement and the performance of the Corporation.

 

		4.8	Upon termination of this Agreement for any reason, the Consultant shall be entitled to receive any Compensation
earned up to the Termination Date, in addition to any other severance or termination payments which are payable under the terms of this
Agreement.

 

ARTICLE
V.

TERMINATION BY CORPORATION

 

		5.1	The Corporation shall be entitled to terminate this Agreement at any time, for any reason, upon written
Notice to the Consultant, in which case:

 

		(a)	subject to Section 6.3, the Corporation shall pay the Consultant an amount equal to the Consultant’s
compensation for the Severance Period in full and final settlement of any claims by the Consultant against the Corporation or any Related
Corporation, arising out of, or in any way connected to, this Agreement with the Corporation or any Related Corporation, or the termination
of such Agreement, whether at common law or under the provision of any statute or regulation, or pursuant to any agreement between the
Parties.

 

		(b)	the Consultant’s right to receive the payment under this Section 5.1 shall not be subject to any
duty to mitigate, nor affected by any actual mitigation by the Consultant; and

 

		(c)	payment under this Section 5.1 shall be subject to the prior execution by the Consultant of a Settlement
Agreement and Release, on terms acceptable to the Corporation acting reasonably.

 

    6

    

    

 

ARTICLE
VI.

TERMINATION BY CONSULTANT

 

		6.1	The Consultant may terminate this Agreement by providing 90 days’ prior Notice to the Corporation.
Upon receipt of such Notice of termination by the Consultant:

 

		(a)	the Corporation shall be required to pay the Consultant any Compensation earned up to the Termination
Date, and may either require the Consultant to continue to perform his duties until the Termination Date, or dismiss the Consultant at
any time after receipt of the Notice, providing Compensation for the Notice Period equal to two months multiplied by the monthly instalment
of the Consulting Fee;

 

		(b)	If the Consultant has terminated this Agreement with the Corporation for any reason other than the occurrence
of a Change of Control of the Corporation then one hundred percent (100%) of both the vested and unvested portion of all stock options
held by the Consultant as of the Termination Date shall be cancelled as of the Termination Date.

 

		6.2	Subject to the conditions set out in Section 6.4, the Consultant may terminate this agreement with the
Corporation within 60 days following the occurrence of a Change of Control of the Corporation and receive the payment set out in section
6.3.

 

		6.3	In the event that the Consultant’s agreement with the Corporation is terminated in strict accordance
with Section 6.2, the Corporation shall pay the Consultant the following amounts in full and final settlement of any claims by the Consultant
against the Corporation or any Related Corporation, arising out of or in any way connected to the Consultant’s agreement with the
Corporation or any Related Corporation, or the termination of such agreement, whether at common law or under the provision of any statute
or regulation, or pursuant to the terms of any agreement between the Parties:

 

		(a)	Compensation calculated for the Severance Period calculated based upon 6 months plus the number of months
remaining in the Term multiplied by the Consulting Fee. The maximum compensation not to exceed 12 months of pay;

 

		(b)	one hundred percent (100%) of the unvested portion of all stock options held by the Consultant as of the
Termination Date shall be deemed vested and the Consultant shall be entitled to exercise such stock options for a period of six (6) months
following the Termination Date.

 

		6.4	Payment under Section 6.3 shall be subject to the following conditions:

 

		(a)	the prior execution by the Consultant of a Settlement Agreement and Release on terms acceptable to the
Corporation acting reasonably;

 

		(b)	the Consultant’s full co-operation and assistance, in connection with any Change of Control, to
transfer the Consultant’s duties and responsibilities to a replacement at the request of the Corporation and for a period requested
by the Corporation not to exceed 30 days, and the tendering by the Consultant of his resignation from any position he may hold as an officer
or a director of the Corporation and any Related Corporations, at such time as the Corporation may request;

 

		(c)	the Consultant’s right to receive the payment under Section 7.2 shall not be subject to any duty
to mitigate, nor affected by any actual mitigation by the Consultant; and

 

		(d)	payment under Section 6.2 shall be in place of, and not in addition to, any other statutory and common
law severance or termination payment in lieu of reasonable notice which may be made to the Consultant pursuant to any other term or provision
of this Agreement.

 

    7

    

    

 

ARTICLE
VII.

TERMINATION UPON DEATH

 

		7.1	This Agreement shall automatically terminate upon the death of the Dedicated Personnel.

 

ARTICLE
VIII.

PROPERTY RIGHTS

 

		8.1	The Consultant acknowledges and confirms that the Corporation shall be entitled to own and control all
proprietary technology, patentable inventions, discoveries, and improvements, trade secrets, all works subject to copyright, and financial,
operating, and training ideas, processes, and materials, including works of expression and all copyrights in such works, that are developed
for the Corporation, created for the Corporation, or conceived for the Corporation by the Consultant during the course of this Agreement
(collectively referred to as “Contract Developments”), to the extent that such Contract Developments relate to the Corporation’s
Business or if such Contract Developments were in any part undertaken with Corporation supplied software or equipment or on the premises
of the Corporation. Accordingly, the Consultant hereby agrees to disclose, deliver, and assign to the Corporation all such Contract Developments,
and further agrees to execute all documents, patent applications, and arrangements necessary to further document such ownership and/or
assignment and to take whatever other steps may be needed to give the Corporation the full benefit of them.

 

		8.2	The Consultant agrees that all copyrightable materials generated or developed for the Corporation under
this Agreement, including computer programs and documentation, shall be considered works made for hire under the copyright laws of Canada
and the United States and shall, upon creation, be owned exclusively by the Corporation. To the extent that any such materials, under
applicable law, may not be considered works made for hire, the Consultant hereby assigns to the Corporation the ownership of all copyrights
in such materials, without the necessity of any further consideration, and the Corporation shall be entitled to register and hold in its
own name all copyrights in respect of such materials.

 

ARTICLE
IX.

CONFIDENTIAL INFORMATION, NON-SOLICITATION AND NON-COMPETITION

 

		9.1	The Consultant agrees that, so long as this Agreement is in force, it shall not engage in any business
that competes with the Business of the Corporation without informing the Board of Directors of the Corporation. Notwithstanding the foregoing,
the Dedicated Personnel shall remain at liberty to carry out his duties with Aingeal Therapeutics and AJK Biopharmaceutical.

 

		9.2	The Consultant further acknowledges and agrees that in performing the duties and responsibilities pursuant
to this Agreement, he will become knowledgeable with respect to a wide variety of Confidential Information which is the exclusive property
of the Corporation, the disclosure of which would cause irreparable harm to the Corporation. The Consultant therefore agrees that during
the Term and following the termination of this Agreement for any reason, he shall treat confidentially all Confidential Information belonging
to the Corporation and shall not disclose the Confidential Information to any unauthorized persons, except with the express consent of
the Board of Directors, or otherwise as required by law.

 

		9.3	The Consultant further agrees that:

 

		(a)	the Consultant will not, for a period of two (2) years from the date of termination of this Agreement,
directly or indirectly, through any other party or entity, approach, solicit, entice or attempt to approach, solicit or entice any of
the other shareholders, employees or consultants of the Corporation, or anyone who was a shareholder, employee or consultant of the Corporation
during the one (1) year prior to termination of this Agreement, to leave the Corporation;

 

    8

    

    

 

		(b)	the Consultant acknowledges and agrees that the foregoing time limits are reasonable and properly required
for the adequate protection of the business of the Corporation, and in the event that any time limitation is deemed to be unreasonable
or unenforceable by a Court of competent jurisdiction, the Consultant agrees and submits to the reduction of the time limitation to such
period as the Court shall deem to be reasonable and enforceable;

 

		(c)	the Consultant agrees that the restrictions and covenants contained in this Section 9.3 shall be construed
independent of any other provision of this Agreement, and the existence of any claim or cause of action by the Consultant against the
Corporation, whether predicated on this Agreement or otherwise, shall not constitute a defence to the enforcement by the Corporation of
the covenants or restrictions contained herein, provided however that if any provision hereof shall be held to be illegal, invalid or
unenforceable in any jurisdiction by a Court of competent jurisdiction, such decision shall not effect any other covenants or provisions
of this Agreement or the application of any other covenant or provision;

 

		(d)	the Consultant agrees that all restrictions contained in this Section 9.3 are reasonable and valid in
the circumstances and all defences to the strict enforcement thereof by the Corporation are hereby waived by the Consultant.

 

		9.4	In the event that this Agreement is terminated in accordance with Sections 5.1 or 6.2, the Consultant
acknowledges and agrees that for a further period equal to three (3) months, it shall not for any reason, either directly or indirectly
through any Person, agent, employee, Affiliate or representative:

 

		(a)	purchase, offer or agree to purchase, directly or indirectly, more than 5% of the outstanding securities
of the Corporation or a Related Corporation (other than through the exercise of currently outstanding options);

 

		(b)	make, or in any way participate in, either directly or indirectly, any non-management solicitation of
any proxy to vote or any consent with respect to any Shares;

 

		(c)	form, join or in any way participate in a group in connection with any of the foregoing; or

 

		(d)	otherwise act, alone or in concert with others, to seek to control or influence the management or the
Board of Directors or policies of the Corporation.

 

		9.5	The Consultant further acknowledges and agrees that pursuant to the terms of this Agreement, that to the
extent he acquires Corporate Property of the Corporation, it shall remain the exclusive property of the Corporation. Upon termination
of this Consultant Consulting Agreement for any reason, the Consultant shall return to the Corporation all Corporate Property, together
with any copies or reproductions thereof; which may have come into the Consultant’s possession during the course of or pursuant
to this Agreement, and shall delete or destroy all computer files on his personal computer which may contain any Confidential Information
belonging to the Corporation.

 

    9

    

    

 

ARTICLE
X.

INDEMNIFICATION AND INSURANCE

 

		10.1	Subject to the requirements of the Act, the Corporation shall indemnify and save harmless the Consultant
from and against any personal liability which he incurs as a direct result of performing his duties on behalf of the Corporation, with
the exception of any liability which the Corporation is prohibited by law from assuming.

 

		10.2	The Corporation agrees to maintain directors and officers liability insurance for the benefit of the Dedicated
Personnel while the Dedicated Personnel remains an officer of the Corporation and shall, at the Consultant’s option or direction,
provide such insurance for the Dedicated Personnel on a run-off basis upon termination of this Agreement pursuant to Section 5.1 and Articles
XI and XII only, for a period of three (3) years from the Termination Date, on commercially reasonable terms.

 

		10.3	The provisions of this Article XIII shall remain in full force and effect notwithstanding the termination
of this Agreement for any reason.

 

ARTICLE
XI.

NOTICES

 

		11.1	Any Notice required to be given hereunder may be provided by personal delivery, by registered mail or
by facsimile to the Parties hereto at the following addresses:

 

To the Corporation:

 

c/o TingleMerrett LLP

1250, 639 — 5th Street, S.W.

Calgary, Alberta T2P 0M9

sreeves@tinglemerrett.com

 

Attention:Scott Reeves, Corporate
Secretary

 

To the Consultant:

 

	 	Address:	26421 Paseo Infinita
	 	 	San Juan Capistrano, CA 92675
	 	Attention:	Dr. Assad Kazeminy
	 	Email:	assadkazeminy@gmail.com

 

Any Notice, direction or other instrument
shall, if delivered, be deemed to have been given and received on the business day on which it was so delivered, and if not a business
day, then on the business day next following the day of delivery, and, if mailed, shall be deemed to have been given and received on the
fifth day following the day on which it was so mailed, and, if sent by facsimile transmission, shall be deemed to have been given and
received on the next business day following the day it was sent.

 

		11.2	Either Party may change its address for Notice in the aforesaid manner.

 

    10

    

    

 

ARTICLE
XII.

GENERAL

 

		12.1	Time shall be of the essence in this Agreement,

 

		12.2	This Agreement shall be construed and enforced in accordance with the laws of the Province of British
Columbia, and the Parties hereby attorn to the non-exclusive jurisdiction of British Columbia Courts. Should provisions in this Agreement
fail to comply with the applicable legislation, the Agreement shall be interpreted in accordance with those statutory requirements.

 

		12.3	This Agreement and any other agreements expressly incorporated by reference herein, constitute the entire
agreement between the Parties with respect to the subject matter hereof, and supercede and replace any and all prior agreements, undertakings,
representations or negotiations pertaining to the subject matter of this Agreement. The Parties agree that they have not relied upon any
verbal statements, representations, warranties or undertakings in order to enter into this Agreement. In the event of a conflict between
this Agreement and any other agreement expressly incorporated by reference herein, the terms of this Agreement shall prevail.

 

		12.4	This Agreement may not be amended or modified in any way except by written instrument signed by the Parties
hereto.

 

		12.5	This Agreement shall enure to the benefit of and be binding upon the Parties hereto, together with their
personal representatives, successors and permitted assigns.

 

		12.6	This Agreement may not be assigned by either Party without the prior consent of the other Party.

 

		12.7	The waiver by either Party of any breach of the provisions of this Agreement shall not operate or be construed
as a waiver by that Party of any other breach of the same or any other provision of this Agreement.

 

		12.8	The Parties agree to execute and deliver such further and other documents, and perform or cause to be
performed such further and other acts and things as may be necessary or desirable in order to give full force and effect to this Agreement.

 

		12.9	The Consultant agrees that following the termination of this Agreement with the Corporation for any reason,
the Consultant shall tender his resignation from any position he may hold as an officer or director of the Corporation or any Related
Corporation.

 

		12.10	Should any provision in this Agreement be found to be invalid, illegal or unenforceable, the validity,
legality or enforceability of the remaining provisions of the Agreement shall not be affected or impaired thereby in any way.

 

IN WITNESS WHEREOF the Parties hereto acknowledge
and agree that they have read and understand the terms of this Agreement, and that they have had an opportunity to seek independent legal
advice prior to entering into this Agreement, and that they have executed this Agreement with full force and effect from the date first
written above.

 

	 

    AJK
BIOPHARMACEUTICAL LLC CANADIAN CONSULTING SERIES

     
	 	HOLLYWEED
    NORTH CANNABIS INC.
	Per	/s/
Assad Kazeminy	 	Per:	/s/
    Authorized signatory
	Dr.
    Assad Kazeminy, President	 	 
	 	 
	 	Per:	 

 

    11

    

    

 

SCHEDULE A

DESCRIPTION OF SERVICES

 

    A-1Exhibit 10.9

 

Consulting Agreement

 

THIS CONSULTING AGREEMENT (the “Agreement”)
is dated this 16th day of December, 2020

 

Client (the “Client”)

 

Hollyweed North Cannabis Inc.

 

3974 Lexington Ave, Victoria, BC V8N 3Z6

 

Consultant (the “Consultant”)

 

Livio Susin

 

103-2197 west 2nd Ave

 

Vancouver, BC V6K 1H7

 

BACKGROUND

 

		A.	The Client is of the opinion that the Consultant has the necessary qualifications, experience and abilities
to provide consulting services to the Client.

 

		B.	The Consultant is agreeable to providing such consulting services to the Client on the terms and conditions
set out in this Agreement.

 

IN CONSIDERATION OF the matters described
above and of the mutual benefits and obligations set forth in this Agreement, the receipt and sufficiency of which consideration is hereby
acknowledged, the Client and the Consultant (individually the “Party” and collectively the “Parties” to this Agreement)
agree as follows:

 

SERVICES PROVIDED

 

		1.	The Client hereby agrees to engage the Consultant to provide the Client with the following consulting
services (the “Services”):

 

		●	Executive Administration Advisory and Consulting Services for HollyWeed North Cannabis Inc. and its subsidiaries
HollyWeed Manufacturing & Extracts Inc. and TerraCube International Inc.

 

		2.	The Services will also include any other consulting tasks which the Parties may agree on. The Consultant
hereby agrees to provide such Services to the Client.

 

TERM OF AGREEMENT

 

		3.	The term of this Agreement (the “Term”) will begin on Dec 16, 2020 and will remain in full
force and effect with the Client until terminated as provided in this Agreement.

 

     

     

    

 

		4.	In the event that either Party wishes to terminate this Agreement, that Party will be required to provide
10 days’ written notice to the other Party.

 

		5.	In the event that either Party breaches a material provision under this Agreement, the non-defaulting
Party may terminate this Agreement immediately and require the defaulting Party to indemnify the non-defaulting Party against all reasonable
damages.

 

		6.	This Agreement may be terminated at any time by mutual agreement of the Parties.

 

		7.	Except as otherwise provided in this Agreement, the obligations of the Consultant will end upon the termination
of this Agreement.

 

PERFORMANCE

 

		8.	The Parties agree to do everything necessary to ensure that the terms of this Agreement take effect.

 

CURRENCY

 

		9.	Except as otherwise provided in this Agreement, all monetary amounts referred to in this Agreement are
in CAD (Canadian Dollars).

 

COMPENSATION

 

		10.	The Consultant will charge the Client for the Services at the rate of $12 500 per month (the “Compensation”).

 

		11.	The Client will be invoiced at the end of every month.

 

		12.	Invoices submitted by the Consultant to the Client are due upon receipt.

 

		13.	The Compensation as stated in this Agreement does not include sales tax, or other applicable duties as
may be required by law. Any sales tax and duties required by law will be charged to the Client in addition to the Compensation.

 

REIMBURSEMENT OF EXPENSES

 

		14.	The Consultant will be reimbursed from time to time for reasonable and necessary expenses incurred by
the Consultant in connection with providing the Services.

 

		15.	All expenses must be pre-approved by the Client.

 

    2

     

    

 

CONFIDENTIALITY

 

		16.	Confidential information (the “Confidential Information”) refers to any data or information
relating to the business of the Client which would reasonably be considered to be proprietary to the Client including, but not limited
to, accounting records, business processes, and client records and that is not generally known in the industry of the Client and where
the release of that Confidential Information could reasonably be expected to cause harm to the Client.

 

		17.	The Consultant agrees that they will not disclose, divulge, reveal, report or use, for any purpose, any
Confidential Information which the Consultant has obtained, except as authorized by the Client or as required by law. The obligations
of confidentiality will apply during the Term and will survive 5 years upon termination of this Agreement.

 

		18.	All written and oral information and material disclosed or provided by the Client to the Consultant under
this Agreement is Confidential Information regardless of whether it was provided before or after the date of this Agreement or how it
was provided to the Consultant.

 

OWNERSHIP OF INTELLECTUAL PROPERTY

 

		19.	All intellectual property and related material, including any trade secrets, moral rights, goodwill, relevant
registrations or applications for registration, and rights in any patent, copyright, trademark, trade dress, industrial design and trade
name (the “Intellectual Property”) that is developed or produced under this Agreement, will be the sole property of the Client.
The use of the Intellectual Property by the Client will not be restricted in any manner.

 

		20.	The Consultant may not use the Intellectual Property for any purpose other than that contracted for in
this Agreement except with the written consent of the Client. The Consultant will be responsible for any and all damages resulting from
the unauthorized use of the Intellectual Property.

 

RETURN OF PROPERTY

 

		21.	Upon the expiry or termination of this Agreement, the Consultant will return to the Client any property,
documentation, records, or Confidential Information which is the property of the Client.

 

CAPACITY/INDEPENDENT CONTRACTOR

 

		22.	In providing the Services under this Agreement it is expressly agreed that the Consultant is acting as
an independent contractor and not as an employee. The Consultant and the Client acknowledge that this Agreement does not create a partnership
or joint venture between them, and is exclusively a contract for service.

 

    3

     

    

 

RIGHT OF SUBSTITUTION

 

		23.	Except as otherwise provided in this Agreement, the Consultant may, at the Consultant’s absolute
discretion, engage a third party sub-contractor to perform some or all of the obligations of the Consultant under this Agreement and the
Client will not hire or engage any third parties to assist with the provision of the Services.

 

		24.	In the event that the Consultant hires a sub-contractor:

 

		●	the Consultant will pay the sub-contractor for its services and the Compensation will remain payable by the Client to the Consultant.

 

		●	for the purposes of the indemnification clause of this Agreement, the sub-contractor is an agent of the Consultant.

 

AUTONOMY

 

		25.	Except as otherwise provided in this Agreement, the Consultant will have full control over working time,
methods, and decision making in relation to provision of the Services in accordance with the Agreement. The Consultant will work autonomously
and not at the direction of the Client. However, the Consultant will be responsive to the reasonable needs and concerns of the Client.

 

EQUIPMENT

 

		26.	Except as otherwise provided in this Agreement, the Consultant will provide at the Consultant’s
own expense, any and all equipment, software, materials and any other supplies necessary to deliver the Services in accordance with the
Agreement.

 

NO EXCLUSIVITY

 

		27.	The Parties acknowledge that this Agreement is non-exclusive and that either Party will be free, during
and after the Term, to engage or contract with third parties for the provision of services similar to the Services.

 

NOTICE

 

		28.	All notices, requests, demands or other communications required or permitted by the terms of this Agreement
will be given in writing and delivered to the Parties at the following addresses:

 

		●	HollyWeed North Cannabis Inc.

 

3974 Lexington Ave, Victoria, BC V8N 3Z6

 

		●	Livio Susin

 

103-2197 w 2nd Ave. Vancouver, BC V6K 1H7

 

or to such other address as
either Party may from time to time notify the other.

 

    4

     

    

 

INDEMNIFICATION

 

		29.	Except to the extent paid in settlement from any applicable insurance policies, and to the extent permitted
by applicable law, each Party agrees to indemnify and hold harmless the other Party, and its respective directors, shareholders, affiliates,
officers, agents, employees, and permitted successors and assigns against any and all claims, losses, damages, liabilities, penalties,
punitive damages, expenses, reasonable legal fees and costs of any kind or amount whatsoever, which result from or arise out of any act
or omission of the indemnifying party, its respective directors, shareholders, affiliates, officers, agents, employees, and permitted
successors and assigns that occurs in connection with this Agreement. This indemnification will survive the termination of this Agreement.

 

ADDITIONAL CLAUSES

 

		30.	Monthly time commitment is 40 hours/week.

 

		31.	Payment is due in 50% cash on a monthly basis with the remaining 50% on an earned and accrued basis or
where funds are not available, 100% on an earned and accrued basis to be paid in full, upon termination of this agreement or financing/sale,
whichever comes first.

 

		32.	5% GST will be added to the monthly invoice amount once the accrued service amount exceeds $30,000.

 

MODIFICATION OF AGREEMENT

 

		33.	Any amendment or modification of this Agreement or additional obligation assumed by either Party in connection
with this Agreement will only be binding if evidenced in writing signed by each Party or an authorized representative of each Party.

 

TIME OF THE ESSENCE

 

		34.	Time is of the essence in this Agreement. No extension or variation of this Agreement will operate as
a waiver of this provision.

 

ASSIGNMENT

 

		35.	The Consultant will not voluntarily, or by operation of law, assign or otherwise transfer its obligation
sunder this Agreement without the prior written consent of the Client.

 

ENTIRE AGREEMENT

 

		36.	It is agreed that there is no representation, warranty, collateral agreement or condition affecting this
Agreement except as expressly provided in this Agreement.

 

ENUREMENT

 

		37.	This Agreement will enure to the benefit of and be binding on the Parties and their respective heirs,
executors, administrators and permitted successors and assigns.

 

    5

     

    

 

TITLES/HEADINGS

 

		38.	Headings are inserted for the convenience of the Parties only and are not to be considered when interpreting
this Agreement.

 

GENDER

 

		39.	Words in the singular mean and include the plural and vice versa. Words in the masculine mean and include
the feminine and vice versa.

 

GOVERNING LAW

 

		40.	This Agreement will be governed by and construed in accordance with the laws of the Province of British
Columbia.

 

SEVERABILITY

 

		41.	In the event that any of the provisions of this Agreement are held to be invalid or unenforceable in whole
or in part, all other provisions will nevertheless continue to be valid and enforceable with the invalid or unenforceable parts severed
from the remainder of this Agreement.

 

WAIVER

 

		42.	The waiver by either Party of a breach, default, delay or omission of any of the provisions of this Agreement
by the other Party will not be construed as a waiver of any subsequent breach of the same or other provisions

 

    6

     

    

 

	IN WITNESS WHEREOF the Parties have duly affixed their signatures under hand and seal on this	16th day of December    , 2020

	 
	HollyWeed North Cannabis Inc.
	 
	Per:	/s/ Authorized Signatory	(Seal)
	 
	Livio Susin
	 
	Per:	/s/ Livio Susin	(Seal)

 

 

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]